Related by context. All words. (Click for frequent words.) 68 Cardiovascular Devices 68 Vitro Diagnostic 67 Inc. dba Vitro 66 Enteral Feed Devices 66 Surgical Equipment 65 Wound Closure Devices 65 Cardiovascular Monitoring 65 Electrophysiology Mapping 64 Dental Devices 64 Endoscopy Laparoscopy 63 Stakeholder Opinions 63 Vitro Diagnostics IVD 63 vitro diagnostics 63 Inc. OTCBB VODG 63 Pipeline Analysis 62 Patient Monitoring Devices 62 Trauma Fixation 62 Endoscopy Devices 62 Vitro Diagnostics Market 62 Interventional Cardiology Devices 61 PharmaVitae Profile 61 Biopharma OTCBB VODG 61 Vitro Technologies 61 Cardiovascular Prosthetic Devices 61 Therapeutic Monoclonal Antibodies 61 Patient Monitoring 61 Therapeutic Competitors 61 Wound Care Management 61 Orthopedic Devices 60 Metabolic Endocrinology 60 Flow Cytometry 60 Drug Delivery 60 Diagnostic Devices 60 Theranostics 60 Inc Therapeutic Competitors 60 Diagnostic Imaging Devices 60 Espicom Business Intelligence 59 Teleflex Incorporated 59 Temperature Monitoring Devices 59 Synthes GmbH 59 vitro diagnostics IVD 59 Novel Therapies 59 Peripheral Vascular Devices 59 Pharmacogenomic 59 Therapeutic Competitors Companies 59 molecular diagnostics 59 Replagal TM 59 Ophthalmic Devices 59 Infectious Disease Testing 59 Multiparameter Patient Monitoring 59 Remote Patient Monitoring 59 Jain PharmaBiotech 59 Monoclonal Antibodies 59 CNS Therapeutics 59 ERYtech 58 Renal Cancer 58 Respiratory Devices 58 HARTMANN GROUP 58 ERYtech Pharma 58 Neurology Devices 58 Tissue Sealants 58 Opportunities Analysis 58 Initiates Clinical Trial 58 OTCBB FCSC biotechnology 58 Compression Therapy 58 Myelodysplastic Syndromes 58 Asthma COPD 58 Ablation Devices 58 Anesthesia Disposables 58 Pink Sheets RHHBY 58 vitro diagnostic 58 Measurement Devices 58 orthopedic biomaterials 58 categories Glucose Monitoring 58 Therapeutic Proteins 58 Companion Diagnostics 58 BioLife Solutions 58 Orthobiologics 58 Anti Infectives 58 Resolvyx Pharmaceuticals 58 Anti infective 57 SWX RO SWX ROG 57 Myocet 57 Neurostimulation Devices 57 Vion Pharmaceuticals 57 Regado Biosciences 57 Molecular Diagnostics 57 Ltd Therapeutic Competitors 57 Pluristem Therapeutics 57 Gene Expression Analysis 57 SYCREST 57 Glucose Monitoring 57 BioPharmaceuticals 57 Anti Infective 57 MultiCell Technologies 57 ICON plc NASDAQ ICLR 57 dba Vitro Biopharma 57 Therapeutic Competitors Report 57 Cancer Therapies 57 AbD Serotec 57 OTCBB IMUC 57 AVAX Technologies Inc. 57 Mesoblast Limited ASX MSB 57 Present Preclinical Data 57 Sleep Apnea Diagnostic 57 Ceflatonin R 57 IGNT 57 ALPCO 57 Rheumatoid Arthritis Drug 57 Biopharmaceuticals 57 Genetic Testing 57 Glass Wool Insulation 56 Kiadis Pharma 56 Vascular Targeting Agents 56 Onko Sure TM 56 Supernus Pharmaceuticals 56 Quark Pharmaceuticals 56 Systemic Delivery 56 EMD Biosciences 56 Therapeutic Vaccines 56 NASDAQ CPHD 56 Insulin Delivery 56 Vitro Diagnostic IVD 56 Molecular Diagnostic Test 56 A5 Laboratories 56 GenPath 56 Chiral Technology 56 Elixir Pharmaceuticals 56 Molecular Diagnostic 56 InNexus Biotechnology 56 Prolongs Survival 56 Bioanalysis 56 Antiviral Therapeutics 56 Wound Dressing 56 Personalised Medicine 56 Alfa Wassermann 56 Repligen Corporation 56 ZEVALIN ® 56 Ossur hf 56 KARL STORZ GmbH 56 Bone Graft Substitutes 56 Infectious Immunology 56 Phase 2a Trial 56 Antimicrobial Coating 56 ABAXIS 56 Files IND 56 Immunochemistry 56 Biopharmaceutical Industry 56 segment Biotest 56 Immunomedics Announces 56 Cardiac Assist Devices 56 Eurand NV EURX 56 Gemin X Biotechnologies 56 Clinical Therapies 56 Spinal Implants 56 Inc. OTCBB SNWV 56 ProRhythm 56 Nasdaq CRXL 56 Drug Repositioning 56 Clinical Trial Results 56 Pepscan Therapeutics 56 AB OMXS BINV 56 Biomarker 55 Therapeutic Competitors companiesandmarkets.com adEgemonye 55 DNA Sequencing 55 OMRIX 55 China Aoxing Pharmaceutical 55 Entest BioMedical 55 Cancer Vaccines 55 Clinical Trial Data 55 Ikaria Holdings Inc. 55 Urology Devices 55 Diagnostic Tests 55 Initiates Clinical Trials 55 Expanded Indication 55 RECOTHROM R 55 Optical Coatings 55 ad hoc news.de RESEARCH 55 Milestone Payment 55 Eribulin 55 Fibrocell Science Inc. 55 OMRIX Biopharmaceuticals Inc. 55 Incontinence Products 55 TrovaGene 55 Tri Isthmus Group 55 Protein Expression 55 ENLIGHT 55 Veridex LLC 55 Clinical Chemistry Analyzers 55 Acuity Pharmaceuticals 55 QuantRx ® 55 FOLOTYN ® 55 Gene Expression Profiling 55 Laboratory Glassware 55 MorphoSys AG FSE MOR 55 Gets FDA Clearance 55 Aegerion Pharmaceuticals 55 Adamis Pharmaceuticals 55 Nucleic Acids 55 Ichor Medical Systems 55 Aegis Therapeutics 55 Keryx Biopharma 55 Radiopharmaceuticals 55 CardioVascular BioTherapeutics Inc. 55 Benign Prostatic Hyperplasia 55 Injectable Drug 55 Marillion Pharmaceuticals 55 Orthopedic Musculoskeletal Devices 55 Transdermal Drug 55 FDA Clearance 55 OncoGenex Pharmaceuticals Inc. 55 Aestus Therapeutics 55 IV Busulfex 55 Orthopaedics Endoscopy 55 Quark Biotech Inc. 55 Initiates Enrollment 55 NASDAQ CLSN 55 PRNewswire FirstCall Osteotech 55 Sanochemia 55 Flame Retardant Chemicals 55 Analytical Tool 55 Clinical Therapies Endoscopy 55 Psoriasis Drug 55 ChemGenex Pharmaceuticals Limited 55 Receives Orphan Drug Designation 55 Abbott Molecular 55 ENT Devices 55 botanical therapeutics 55 NASDAQ DIGE 55 Provectus Pharmaceuticals 55 OTCBB ENTB 55 OTCBB FCSC 55 Saladax Biomedical 55 Millennium Biotechnologies 55 DNA Methylation 55 Textile Washing Products 55 Targeted Therapies 55 includes Dideco CarboMedics 55 Sunesis Pharmaceuticals 55 Orthopedic Biomaterials 55 Central Venous Catheters 55 Completes Patient Enrollment 55 Windhover Information Inc. 55 RNAi Therapeutics 55 pharmacogenomics pharmacogenetics 55 Clinical Diagnostics 54 Nastech Pharmaceutical Company 54 plasma protein biotherapeutics 54 Agile Therapeutics 54 NYSE Amex PBTH 54 Initiate Clinical Trial 54 NASDAQ AEZS 54 Gendux AB 54 Bovie Medical Corporation 54 External Defibrillators 54 Antipsychotic Medications 54 Idera Pharmaceuticals 54 Genedata Expressionist ® 54 GeneraMedix 54 Partnering Agreements 54 Announces Poster Presentations 54 Wafer polifeprosan 54 Therapeutic Antibodies 54 Fetal Monitors 54 Orthopedic Devices Investment 54 Meets Primary Endpoint 54 Receives Positive Opinion 54 Fabry Disease 54 QUADRAMET R 54 AQUA ® 54 OTCBB UPBS 54 Epeius Biotechnologies Corporation 54 Metered Dose Inhaler Devices 54 Biosimilar 54 Industrial Enzymes 54 Chemokine Therapeutics 54 Inovio Pharmaceuticals 54 Membrane Separation Technologies 54 Seasonal Influenza Vaccine 54 Ultrasound Equipment 54 Veterinary Vaccines 54 Infusion Pumps 54 Active Ingredients 54 High Growth Forecasted 54 Phase III Trials 54 Akesis Pharmaceuticals 54 Biotest AG 54 Stakeholder Insight 54 SOLVAY PHARMACEUTICALS 54 Contrast Agents 54 Roche SWX ROG.VX 54 OTCBB CGXP 54 Decision Biomarkers 54 Transfection 54 CyDex Pharmaceuticals 54 Chugai Pharma USA 54 Medistem Laboratories 54 Medtech Insight division 54 Bracco Imaging 54 Xennex 54 OTCBB CVBT 54 Orthopedic Implants 54 Radiopharmaceutical 54 Mallinckrodt Imaging 54 Neurostimulation 54 Ambion Diagnostics 54 Cordis Endovascular 54 Maven Semantic http:/www.mavensemantic.com announBruising Brandon 54 OTC BB PVCT 54 Apricus Biosciences 54 Clinical Trials 54 mtm laboratories 54 Microtomes Cryostats & 54 AviaraDx 54 NASDAQ ABII 54 Molecular Biometrics 54 Safinamide 54 Analgesics 54 Infusion Systems 54 Xanthus Pharmaceuticals Inc. 54 Protein Therapeutics 54 Orphan Drugs 54 Amarantus 54 Nasdaq PCOP 54 Branded Pharmaceuticals 54 First Patient Treated 54 Graphics develops manufactures 54 Celliance 54 Impax Pharmaceuticals 54 Wound Care Markets 54 Small Molecule 54 Gentel Biosciences 54 #/#/# Reportlinker.com announces 54 Agios Pharmaceuticals 54 Hematologic Oncology 54 Entest BioMedical Inc. 54 IVD 54 Ascenta Therapeutics 54 Ceragenix 54 Recombinant Human 54 Taligen Therapeutics 54 BioSpecifics Technologies Corp. 54 Survival Benefit 54 NYSE Alternext ULU 54 Antifungals 54 Recombinant Proteins 54 Advanced Colorectal Cancer 54 Aarkstore 54 ProMetic BioSciences 54 Biochip 54 Integromics 54 Kissei Pharmaceutical 54 Smooth Muscle 54 Orphan Diseases 54 NASDAQ ISTA 54 Patent Issuance 54 Antibody Discovery 54 Broadband CPE 54 OTCBB VCRT 54 Arno Therapeutics 54 Alseres Pharmaceuticals Inc. 54 Initiates Clinical 54 Cyntellect 54 Equipment Deals 54 Cardiac Rhythm 54 Image Guided 54 Circ Pharma 54 Nanoemulsion 54 Campath ® 54 Proprietary Products 54 Petroleum Refining Catalysts 54 OTCBB PYTO 53 theranostics 53 Ivax Diagnostics 53 Anticancer Agents 53 ZARS Pharma 53 Taglich Brothers Initiates Coverage 53 Alnara Pharmaceuticals 53 Onalta TM 53 Panacea Pharmaceuticals 53 Hepatitis C Virus 53 VisEn Medical 53 immunodiagnostics 53 Inflammatory Diseases 53 Quark Biotech 53 INTERNATIONAL HOLDINGS INC. 53 XTENT 53 Xenomics 53 Novartis Diagnostics 53 Receives Approvable Letter 53 Kinase Inhibitors 53 PROLOR Biotech Inc. 53 immunodiagnostic 53 Monoclonal Antibody 53 Cara Therapeutics 53 USGI Medical 53 Urinary Incontinence 53 Interventional Products 53 Non Invasive 53 Drug Candidate 53 Ibis Biosciences 53 Respiratory Disorders 53 Mirna Therapeutics 53 http:/www.researchandmarkets.com/reports/c# 53 Biopharma 53 Auxilium Pharma 53 Product Pipeline 53 Biocompatible Materials 53 equine osteoarthritis 53 Cord Blood Stem Cells 53 Cypher Sirolimus 53 Pulmonary Drug 53 FACTIVE R gemifloxacin 53 LeMaitre Vascular Inc. 53 Nasdaq SMTS develops manufactures 53 Immunotherapeutic 53 Prometheus Laboratories 53 Creabilis Therapeutics 53 Anika Therapeutics 53 Biocides 53 Radient Pharma 53 Molecular Profiling Institute 53 biopharmaceuticals 53 Brainstorm Cell Therapeutics 53 Wound Therapeutics Continence 53 Genedata 53 KINAXO 53 Immunotherapies 53 Soft Drink Manufacturing 53 Personalized Immunotherapy 53 Patient Enrollment 53 mSEPT9 53 Autoimmune Disease 53 Tumor Targeting 53 Cepheid CPHD 53 IncellDx 53 OTCBB QTXB 53 Response Genetics 53 Toxicogenomics 53 HepaLife Technologies Inc. 53 GenWay Biotech 53 Pharmion Corporation 53 Successfully Completes Phase 53 OTCBB CAEH 53 Clontech Laboratories Inc. 53 HealthSonix Inc. 53 Celsion Corporation 53 Metabolic Disease 53 RECOTHROM ® 53 Pressure BioSciences 53 PregLem 53 Fiber Optic Sensors 53 Diatos 53 biosurgical 53 Drug Metabolism 53 Biotechnology Instrumentation 53 Anti Tumor 53 AngioChem 53 Michele Garufi Chairman 53 Phase III Clinical Trials 53 Max Neeman International 53 Oncotech 53 Tissue Repair 53 rxRNA 53 SNP Genotyping 53 Announces FDA Clearance 53 QuatRx Pharmaceuticals 53 Hepatocellular Carcinoma 53 Aloxi ® 53 Combination REOLYSIN R 53 QuantRx Biomedical Corporation 53 Insulin Pumps 53 Lupus Nephritis 53 Alaven 53 Myrexis Inc. 53 Vernalis plc 53 Bioenvision Nasdaq BIVN 53 Reportlinker 53 oncology therapeutics 53 Agendia BV 53 OTCBB NRGX 53 Shoulder Prosthesis 53 Extracellular Matrix 53 acne impetigo 53 LEUKINE 53 selective immunoproteasome inhibitor 53 Genesis Bioventures 53 Provides Detailed 53 JCR Pharmaceuticals 53 Radionuclides 53 CytoSorbents Corporation 53 Idenix Pharmaceuticals 53 ZaBeCor 53 FzioMed 53 Markets www.researchandmarkets.com 53 - Aarkstore Enterprise [002] 53 Biodegradable Polymers 53 PBIO 53 Pulmonary Arterial Hypertension 53 Safety Syringes 53 Receives CE Marking 53 Smoking Cessation Aids 53 Cardiometabolic 53 Genes Involved 53 Drug Pipeline 53 Galenea 53 Pivotal Clinical Trial 53 Tibotec BVBA 53 and Markets http:/www.researchandmarkets.com/repoTouchSmart PC 53 Cytori Therapeutics Inc. 53 Cosmeceutical 53 Receives Orphan Drug 53 Accentia Biopharmaceuticals 53 Elagolix 53 Fast Track Status 53 COMPETITIVE LANDSCAPE Total 53 Phase 2b Clinical Trial 53 Biopharmaceutical Manufacturing 53 Sysmex Corporation 53 Spirus Medical 53 Auriga Laboratories Inc. 53 BCLI 53 MicroRNA 53 Digital Radiography 53 Bucindolol 53 Marketing Authorisation Application 53 EMD Biosciences Inc. 53 Avila Therapeutics 53 Granted Orphan Drug 53 Fibrin Patch 53 Gamma Cameras 53 AMEX ONI 53 Affimed Therapeutics AG 53 Clearant Inc. 53 Gene Synthesis 53 Antisense Pharma GmbH 53 Phenomix Corporation 53 Amneal Pharmaceuticals 53 Protein Polymer Technologies 53 ARCALYST R 53 Drug Formulation 53 Misonix Announces 53 ImmunoVaccine Technologies 53 IVOB 53 liver resection surgeries 53 Hypercholesterolemia 53 Cancer Treatments 53 Neurodegenerative 53 Stemedica 53 ophthalmics 53 Nucleic Acid Purification 53 Medtronic CoreValve 53 Patent Covering 53 Protalex Inc. 53 Cardiovascular Devices Market 53 Dr. Cauwenbergh 53 Pemphigus Vulgaris 53 Receives Milestone Payment 53 TSX VENTURE ZMS FRANKFURT 53 IGNT leading 53 Gedeon Richter Plc 53 Cardiovascular Metabolic 53 Cancer Biomarkers 53 SagaX 53 Neulasta R 53 Sinobiomed 53 Oncology Drug 53 VentiRx Pharmaceuticals 53 CINtec R 53 Issued Patent 53 ORENCIA R 53 Neoadjuvant Chemotherapy 53 Biomarker Discovery 53 miRview meso 53 Intendis 53 Harbor BioSciences 53 Pivotal Study 53 Growth Hormone Deficiency 52 Bone Grafts 52 NASDAQ CRXL 52 Paladin Labs 52 Vantia Therapeutics 52 Electrophysiology EP 52 CONMED Corporation 52 Urology Gynecology 52 FORMA Therapeutics 52 Competitive Analysis 52 Arbios Systems Inc. 52 NASDAQ HLCS 52 NeoVisc ® 52 Sterilization Systems 52 Akorn Inc 52 Prism Pharmaceuticals 52 Nautilus Biotech 52 GIPET 52 Civacir 52 Patient Monitoring Market 52 MacroPore Biosurgery 52 Nasdaq MBRX announced 52 Active Biotech AB 52 Therapeutic Antibody 52 NASDAQ PCYC 52 RegeneRx Biopharmaceuticals 52 Patents Issued 52 Cancer Vaccine 52 Orthopedic Implant 52 www.sanuwave.com 52 OncoMethylome Sciences 52 Inflammatory Arthritis 52 ophthalmic pharmaceutical 52 Phase III Trial 52 Naurex 52 Oncology Primary Care 52 Adenosine Therapeutics 52 TUSTIN CA Marketwire #/#/# 52 Seikagaku Corporation 52 Bovie Medical 52 Barrier Therapeutics Inc. 52 Ophthalmic Devices Investment 52 generic injectables 52 Pink Sheets IGNT 52 ISTO Technologies 52 Pharma Biotech 52 tiapamil 52 IsoTis OrthoBiologics 52 Biomaterial 52 CyberKnife Radiosurgery 52 Surgical Navigation 52 AMEX RGN 52 Oncobionic 52 NASDAQ FLML 52 Power3 Medical 52 molecular diagnostic 52 PRNewswire FirstCall YM BioSciences 52 Genetic Diseases 52 Image Guided Surgery 52 Randomized Clinical Trials 52 Receives SFDA Approval 52 Inc. NASDAQ AVNR 52 Visit www.BASInc.com 52 Biologics Manufacturing 52 Markets www.researchandmarkets.com/reports/c# 52 OTCBB NPHC biotechnology 52 Immunomedics Inc. 52 AngioGenex 52 Insulin Delivery Systems 52 Ion Channels 52 TCA Cellular Therapy 52 Stationary Fuel Cells 52 Kiadis 52 OPKO Health 52 Microfluidic Systems 52 bioMerieux SA 52 Immunodiagnostics 52 Nasdaq IVGN 52 synthetic nucleic acid 52 ChromoCure Inc. 52 Digital Thermometers Infrared 52 Nymox Pharmaceutical Corporation 52 ImQuest Pharmaceuticals 52 Inc. OTCBB GNLK 52 Nihon Kohden Corporation 52 NASDAQ BTRX pharmaceutical 52 NanoBiology 52 Merck KGaA Darmstadt Germany 52 Metabolic Disorder 52 ImmunoCellular 52 DNA Microarray 52 Presents Positive 52 multiparameter patient monitoring 52 Savory Snacks 52 Report companiesandmarkets.com adds 52 IRIDEX Corporation 52 Diabetic Macular Edema 52 Oncolys BioPharma 52 Liprotamase 52 SQI Diagnostics 52 Animal Feed Additives 52 Catalyst Biosciences 52 TSX VENTURE SVA 52 Ascent Therapeutics 52 Sunshine Biopharma 52 Antisense Pharma 52 Announcement acc 52 SPECT Single Photon 52 Therapeutic Vaccine 52 SIX RO ROG 52 Solar Photovoltaic Market 52 Tibotec Pharmaceuticals Ltd. 52 Pulse Oximeters 52 PRNewswire FirstCall Nastech Pharmaceutical 52 Imaging Clinical Trial 52 Commercialize Novel 52 Akebia Therapeutics 52 Cancer Stem Cells 52 Exagen Diagnostics 52 EyeGate Pharma 52 Crop BioScience 52 Thin Film Photovoltaics 52 DJO Incorporated 52 Gastrointestinal Disorders 52 Selvita 52 Amira Pharmaceuticals 52 Hybridon 52 Nymox NX 52 Cellix 52 Gaucher Disease 52 Expression Pathology 52 Aphton Corporation 52 Improved Survival 52 OTCBB AFLB 52 Novartis Molecular Diagnostics 52 Evoltra ® 52 ASX PGL 52 Capsulution 52 Oral Mucositis 52 vivo fluorescence imaging 52 ImmuneRegen BioSciences Inc. 52 MEDRAD INC. 52 Milnacipran 52 Edimer Pharmaceuticals 52 Pharmaxis ASX PXS 52 Debiopharm SA 52 OTCBB HXBM developer 52 Anti CD# Antibody 52 Prodarsan R 52 OTCBB NVLT biopharmaceutical 52 OPi 52 Nasdaq ISTA 52 Antitumor Activity 52 Investigational Compound 52 MarketsandMarkets Global 52 immunochemistry 52 Preclinical Study 52 Proteo 52 Submits NDA 52 Hydromer Inc. 52 Monoclonal antibody 52 REPRONEX R menotropins 52 ESBATech 52 Surgical Procedures 52 Semafore Pharmaceuticals 52 Cynapsus formerly 52 Encysive Pharmaceuticals 52 Progenics Pharmaceuticals 52 Immunoassays 52 Novel Oral 52 Detailed Product 52 Oxford Genome Sciences 52 BioForce Nanosciences 52 Orchid BioSciences 52 DermTech 52 Synosia Therapeutics 52 Blood Clotting 52 Phase IIb Clinical Trial 52 Silodosin 52 STEMCELL Technologies 52 HCV Protease Inhibitor 52 BioPharm 52 Immunoassay 52 NYSE Amex AEN 52 FDA Approvals 52 Phase III Clinical Trial 52 TKPHF 52 Advanced Biotherapy 52 Cord Blood Banking 52 vitro diagnostic tests 52 TRACON Pharmaceuticals 52 Reata Pharmaceuticals 52 Technological Advances 52 LeMaitre Vascular 52 Metabolic Disorders 52 Regulus Therapeutics 52 Shows Promising 52 AcuFocus 52 DARA BioSciences 52 Previously Treated 52 OTCBB ARGA specialty 52 Transcept Pharmaceuticals 52 GTC NASDAQ GTCB 52 Advanced Renal Cell 52 neurology immunology 52 t2cure GmbH 52 PsychoGenics 52 Global Generics 52 ProEthic Pharmaceuticals 52 Urology Devices Market 52 Multiple Myeloma Patients 52 Dexo 52 ThermoDox R 52 Manja Bouman CEO 52 Biosite Incorporated 52 PCRX 52 JAK Inhibitor 52 Household Appliances Sales 52 Applied NeuroSolutions 52 SWX ROG Pink Sheets 52 NDA Submission 52 Kensey Nash Corporation 52 entitled Formulary Advantages 52 PRNewswire FirstCall Cepheid 52 products BioTime develops 52 Files Patent Application 52 IDEV Technologies 52 Implantable Device 52 Progenitor Cell 52 Ercole Biotech 52 GeneraMedix Inc. 52 Terumo Corporation 52 Antigen CEA 52 Senesco Technologies 52 Nippon Kayaku 52 BioFocus DPI Galapagos 52 ImmunoCellular Therapeutics Ltd. 52 Rosetta Genomics Nasdaq ROSG 52 VIA Pharmaceuticals 52 Artificial Organs 52 EntreMed Inc. 52 Aviptadil 52 LYON France BUSINESS WIRE 52 Migraine Drug 52 Cytometry 52 diagnostics therapeutics 52 B. Braun Melsungen 52 Bioheart Inc. 52 Regenerative Cells 52 Receives Marketing Authorization 52 Source MDx 52 Novelos Therapeutics 52 Pressure Sensitive Tapes 52 Protein Interaction 52 Fero Industries Inc. 52 NASDAQ CORT 52 Rosetta Genomics Ltd. 52 Dyslipidemia 52 PRNewswire FirstCall Pharmacopeia 52 CRMD pharmaceutical 52 Indegene 52 Cavit Sciences Inc. 52 Tyrosine Kinase Inhibitor 52 Zemiva TM 52 Cutaneous T 52 Syndax Pharmaceuticals Inc. 52 Nasdaq AUXL 51 IND Filing 51 Urodynamix 51 Acute Ischemic Stroke 51 neurostimulation devices 51 NASDAQ DCGN 51 Dynal 51 Drug Eluting Stent 51 Cardiac Rhythm Management 51 Espicom 51 Custom Synthesis 51 Inc. AMEX YMI 51 Echelon Biosciences 51 Maven Semantic 51 Helsinn 51 Optical Biopsy 51 Disease IBD 51 Drug Eluting 51 Prognostic Value 51 Curon Medical 51 Reagents 51 Feed Acidifiers 51 Immunotope 51 Opko Health Inc. 51 Mersana Therapeutics Inc. 51 Progenitor Cells 51 ICON NASDAQ ICLR 51 Oral Fluid 51 Cx# [002] 51 Dr. Stylli 51 personalized cellular immunotherapy 51 GenVault Corporation 51 Improves Survival 51 Drug Shows Promise 51 FDA Okays 51 Competitive Structure 51 YONDELIS R 51 SHP.L 51 Antibody Therapeutics 51 Hematology Molecular Pathology 51 Alinia 51 IVD Market 51 Antisense Drug 51 TFT LCD Panels 51 Immune Cell 51 Overactive Bladder 51 oncology immunology 51 visit http:/www.mannkindcorp.com 51 FUSILEV ® 51 therapeutic monoclonal antibodies 51 DSM DSM 51 Inc. OTCBB CADM 51 Astralis Ltd. 51 ARKRAY 51 LEVADEX ™ 51 Quotient Bioresearch 51 Patent Broadly Covering 51 Investigational Drugs 51 UMN Pharma 51 ISTO Technologies Inc. 51 Selexis 51 Diastolic Heart Failure 51 Takara Bio Inc. 51 Nasdaq HALO 51 Caleco Pharma 51 ImmunoCellular Therapeutics 51 Drug Discovery 51 Complicated Skin 51 Prostate Cancer Vaccine 51 Kedrion 51 label Lipofen R 51 Kapa Biosystems 51 Avian Flu Vaccine 51 Loramyc ® 51 Osmetech plc 51 AIM OBP 51 IMS MIDAS 51 Noscira 51 Infectech 51 Oral Interferon 51 Medistem 51 Computed Radiography 51 Generex Biotechnology 51 BioSystems 51 Response Genetics Inc. 51 Orthopaedic Reconstruction Orthopaedic Trauma 51 Anti Tumor Activity 51 non invasive cardiorespiratory 51 Pivotal Phase III 51 Immune Mediated 51 Intravenous Equipment 51 Phytomedics Inc. 51 ProFibrix 51 Blood Pressure Monitoring 51 Study Evaluating 51 Cancer Immunotherapy 51 carmustine implant 51 Initiates Dosing 51 EOS NASDAQ MELA 51 Fosphenytoin 51 Confirms Efficacy 51 Bio Pharmaceutical 51 Cardiac Marker 51 Akela Pharma Inc. 51 ENT Devices Investment 51 Ore Pharmaceuticals 51 Corixa Corporation 51 Completes Enrollment 51 MOVIPREP R 51 renin inhibition promising 51 Multiferon R 51 Chronic Heart Failure 51 Prospective Randomized 51 diagnostic molecular imaging 51 Merz Pharma Group 51 Analytical Instrumentation 51 Fresenius Biotech 51 ClinTec International 51 Severe Sepsis 51 Ikonisys 51 Therapeutic Potential 51 NASDAQ OGXI 51 Testosterone Gel 51 BioTrends Research Group 51 Obtains CE Mark 51 Trellis Bioscience 51 glucokinase activator 51 R bortezomib 51 Regenerative Cell 51 Interventional Neurology 51 NASDAQ CYTX 51 ARIUS Research 51 Lung Cancer Drug 51 HYVISC R 51 Bionanotechnology 51 Collaborators Publish 51 Millennium Biotechnologies Group 51 NEXUS Biosystems 51 Progenika 51 Gliadel R 51 Perflubutane Polymer Microspheres 51 Cardiovascular Devices Investment 51 Cellular Therapies 51 Corgenix Medical Corporation 51 ProLindac TM 51 SafeStitch Medical 51 PGx 51 Indevus Pharma 51 Takeda Pharma 51 ARC Specialty 51 ESBATech AG 51 Inc. NASDAQ AEZS 51 Rexahn Pharmaceuticals 51 eGene Inc. 51 ImmunoGen Inc. 51 BioSurgery